Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Pati
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| Amarin Corp Plc (NASDAQ: AMRN) | Delayed: 12.11 -0.62 (4.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.73 | 52 Week High | $3.65 | |||
| Open | $12.71 | 52 Week Low | $1.24 | |||
| Day High | $12.76 | P/E | N/A | |||
| Day Low | $12.00 | EPS | $0.00 | |||
| Volume | 101,278 | |||||
